Q3 2020 Holdings
Filed 2020-11-13 | 62 holdings | $262.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Exelixis Inc(EXEL) | COM | 30161Q104 | $374 | 15,300 | 0.0% |
| Spring BK Pharmaceuticals in | COM | 849431101 | $1.3K | 941,171 | 0.0% |
| Regulus Therapeutics Inc | COM NEW | 75915K200 | $1.7K | 3,217,480 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM NEW | 867328874 | $2.2K | 1,727,308 | 0.0% |
| Biolinerx LTD | SPONSORED ADS | 09071M205 | $2.8K | 1,686,375 | 0.0% |
| Novus Therapeutics Inc | COM | 67011N105 | $3.3K | 3,515,873 | 0.0% |
| Erytech Pharma | SPONSORED ADR | 29604W108 | $3.9K | 625,000 | 0.0% |
| Forward Pharma A/S | SPONSORD ADS NEW | 34986J204 | $4.0K | 647,299 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $4.3K | 3,650,000 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $4.6K | 1,100,000 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $5.4K | 792,892 | 0.0% |
| Galmed Pharmaceuticals LTD(GLMD) | SHS | M47238106 | $6.4K | 1,799,694 | 0.0% |
| Evelo Biosciences Inc | COM | 299734103 | $6.9K | 1,300,000 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $8.3K | 800,000 | 0.0% |
| Contrafect Corp(CFRXUSD) | COM NEW | 212326300 | $8.4K | 1,600,000 | 0.0% |
| Gamida Cell LTD | SHS | M47364100 | $8.9K | 2,143,667 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | COM NEW | 372427401 | $9.2K | 4,012,404 | 0.0% |
| Panacea Acquisition Corp | UNIT 99/99/9999 | 698102209 | $9.6K | 800,000 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $10.7K | 3,766,704 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $11.4K | 5,494,582 | 0.0% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $11.8K | 322,098 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $12.7K | 4,080,162 | 0.0% |
| Verastem Inc | COM | 92337C104 | $13.0K | 10,747,994 | 0.0% |
| Therapeutics Acquisition COR | COM CL A | 88339T103 | $14.4K | 1,000,000 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $14.9K | 6,929,690 | 0.0% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $15.0K | 1,344,334 | 0.0% |
| Calithera Biosciences Inc(CALAEUR) | COM | 13089P101 | $15.8K | 4,585,638 | 0.0% |
| Calliditas Therapeutics AB | SPONSORED ADS | 13124Q106 | $18.0K | 750,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $18.1K | 1,227,405 | 0.0% |
| Infinity Pharmaceuticals Inc(INFIQ) | COM | 45665G303 | $20.4K | 17,426,968 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $20.7K | 3,005,589 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $20.8K | 3,622,051 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $21.0K | 8,459,547 | 0.0% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $22.2K | 7,244,262 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $23.5K | 2,149,057 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $31.0K | 3,087,195 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $34.9K | 735,055 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $36.5K | 2,470,678 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $37.6K | 8,009,353 | 0.0% |
| Forte Biosciences Inc(TOCAEUR) | COM | 34962G109 | $37.7K | 777,553 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $38.7K | 3,499,346 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $38.9K | 1,691,834 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $40.5K | 3,226,769 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $42.2K | 1,198,427 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $45.6K | 1,489,112 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $46.4K | 2,372,288 | 0.0% |
| AC Immune SA(ACIU) | SHS | H00263105 | $47.9K | 9,818,758 | 0.0% |
| Merus N V | COM | N5749R100 | $67.7K | 5,645,571 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $73.1K | 2,101,049 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $78.8K | 4,182,243 | 0.0% |